S 1862 · 119th Congress 2025–2027

ORPHAN Cures Act

Fact sheet

Latest action · May 22, 2025 Read twice and referred to the Committee on Finance. (text: CR S3119)

Progress

Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.

  1. IntroducedMay 22, 2025
  2. Passed SenateNot reached
  3. Passed HouseNot reached
  4. To the PresidentNot reached
  5. Became lawNot reached

Summary

Optimizing Research Progress Hope And New Cures Act or the ORPHAN Cures Act

This bill modifies certain provisions under the Medicare Drug Price Negotiation Program with respect to orphan drugs.

The Medicare Drug Price Negotiation Program requires the Centers for Medicare & Medicaid Services to negotiate the prices of certain prescription drugs under Medicare beginning in 2026. Among other requirements, drugs must have had market approval for at least 7 years (for drug products) or 11 years (for biologics) to qualify for negotiation. The program does not apply to orphan drugs that are approved to treat only one rare disease or condition.

The bill modifies these provisions so as to exclude any period in which a drug was an orphan drug from market approval calculations. It also excludes orphan drugs that are approved to treat more than one rare disease or condition from the program.

Cosponsors 1

Members who signed on, in the order they did. All signed on May 22, 2025.

SeatCosponsorSigned on
D-NMMartin HeinrichOriginalMay 22, 2025

Actions 2

Everything that happened, newest first.

  1. May 22, 2025Introduced in Senate
  2. May 22, 2025Read twice and referred to the Committee on Finance. (text: CR S3119)

Related bills 1

Companion bills and other measures the record links to this one.

BillTitleRelationshipLatest action
HR 946ORPHAN Cures ActRelated billFeb 6, 2025

Subjects

Assigned by the Library of Congress. Policy area: Health.

Text 1

Each version as it was printed, newest first.

  1. May 22, 2025Introduced in Senate

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details.

Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov.